腹泻型肠易激综合征发病机制及中药干预研究进展  

Pathogenesis of Diarrhea-predominant Irritable Bowel Syndrome and Its Research Progress of Intervention with Chinese Medicine

作　　者：韩亚飞 王允亮[2] 李军祥[2] 

机构地区：[1]北京中医药大学,北京100029 [2]北京中医药大学东方医院,北京100078

出　　处：《辽宁中医药大学学报》2018年第1期114-117,共4页Journal of Liaoning University of Traditional Chinese Medicine

基　　金：国家科技支撑计划资助项目(2013BAI02B05)

摘　　要：随着现代社会生活节奏的逐步加快和饮食结构的不断变化,肠易激综合征在临床上的发病率呈逐年上升趋势。肠易激综合征（IBS）是临床上常见的消化系统疾病,因其缺乏生化指标的异常改变,因此被称为功能性胃肠道疾病。而腹泻型IBS易复发、病程长、难治愈,因此又被称为慢性难治性疾病。本病的病因及和发病机制较为复杂,目前尚不十分明确。现代医学对本病的治疗效果比较局限,而中医药治疗本病更胜一筹。近几年来中药在治疗IBS方面尤其是腹泻型IBS取得了良好的临床效果,该文主要从腹泻型肠易激综合征的发病机制及中药干预两方面概述其研究进展。With the rapid pace of life in modern society and the changing diet structure,irritable bowel syndrome in the clinical incidence was increasing year by year. Irritable bowel syndrome（IBS）is a common digestive system disease,because of its lack of biochemical indicators of abnormal changes,it is called functional gastrointestinal diseases. And diarrhea-predominant IBS is easy to relapse,difficult to cure,and it has a long course,so it is called chronic refractory disease. The etiology and pathogenesis of this disease is more complex,is not yet clear. In recent years,traditional Chinese medicine in the treatment of IBS,especially diarrhea-predominant IBS achieved good clinical results,the text will overview the pathogenesis of IBS-D and the research progress of the intervention with Chinese medicine.

关 键 词：肠易激综合征 腹泻型 发病机制 中医药 治疗 

分 类 号：R259[医药卫生—中西医结合]